Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Halfdanarson, T R; Rabe, K G; Rubin, J; Petersen, G M

Halfdanarson, T R; Rabe, K G; Rubin, J; Petersen, G M.

Affiliation

Halfdanarson TR; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA. thorvardur-halfdanarson@uiowa.edu

Ann Oncol ; 19(10): 1727-33, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18515795

Subject(s)

Neuroendocrine Tumors/epidemiology; Pancreatic Neoplasms/epidemiology; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors/pathology; Pancreatic Neoplasms/pathology; Prognosis; SEER Program; Sex Factors; Survival Rate/trends; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors Type of study: Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Ann Oncol Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google